Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma. Issue 3 (23rd February 2020) - Sharpley, Faye A.; Djebbari, Faouzi; Fourali, Samih; Kothari, Jaimal; Lynes, John A.; McLain-Smith, Susan; Ramasamy, Karthik